Fermion is a contract manufacturing and API business unit of Orion Corporation, headquartered in Finland. Drug product contract manufacturing services are marketed by Fermion but produced by Orion sites. Focus areas are hormonal and non-hormonal semi-solids, liquids, cytotoxic oral solids and packaging services. Fermion's API portfolio of over 30 products includes innovative and generic APIs. We have extensive experience in developing innovative APIs from Phase I all the way to commercialisation. API CDMO capabilities include highly potent compounds, both cytotoxics and non-cytotoxics. The total reactor capacity for APIs is 340 cubic meters.